CorrlensCorrlens
Correlate

Correlation Analysis

Incyte Genomics Inc vs NetFlix Inc

INCY vs NFLX

+0.232

Light positive

When one moves up, the other tends to follow.

INCY logo

Incyte Genomics Inc

INCY

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Market cap 18.9B · 2,844 employees

NFLX logo

NetFlix Inc

NFLX

Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

Market cap 417.7B

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockConsumer

Time Series

Relative Performance

Green: INCYGray: NFLX36 of 1,254 points (sampled)

Who Moves First

NFLX leads INCY by 6 days

NFLX tends to move before INCY.

After testing 13 timing shifts, the strongest relationship was +0.251 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.087

12 periods · Return correlation when both series rose

Both Falling

-0.387

6 periods · Return correlation when both series fell

Diverging

-0.659

17 periods · Return correlation when series moved apart

R-Squared

5.4%

Share of variance in one series explained by the other.

Trend Agreement

54.5%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.178, 0.283]

Scatter

XY Regression

48.15060708090100106.710.720406080100120133.2Incyte Genomics IncNetFlix IncData pointsFit (r = 0.232)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

INCY logo

Incyte Genomics Inc

INCY

Market cap 18.9B · 2,844 employees

Stock · 1,254 raw → 1,254 prepared

Series B

NFLX logo

NetFlix Inc

NFLX

Market cap 417.7B

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

9

Estimated crossover points between normalized spreads.

Slope

0.5786

Linear regression slope.

Intercept

19.8702

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 5 hours ago · ID: stock-incy-vs-stock-nflx-daily